Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year

Abutaleb, Ameer; Buchwald, Andrea G; Chudy-Onwugaje, Kenechukwu; Langenberg, Patricia; Regueiro, Miguel; Schwartz, David A.; Tracy, J. Kathleen; Ghazi, Leyla; Patil, Seema; Quezada, Sandra; Russman, Katharine; Quinn, Charlene C.; Jambaulikar, Guruprasad; Beaulieu, Dawn B.; Horst, Sara; Cross, Raymond K.

doi:10.1093/ibd/izy149

Cited by 18 publications

(20 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three studies were based on one clinical trial; two of them were RCTs with two different objectives and sample sizes (Abutaleb et al, 2018; Cross et al, 2019), and the third study evaluated the telehealth intervention qualitatively (Reich et al, 2019). The quantitative studies examined the effectiveness of the following interventions: web‐guided intervention, IBD management through an electronic health record patient portal, home tele‐management, telemedicine, short message services (SMS) for remote monitoring, tele‐monitoring using a mobile application, monitoring of fecal calprotectin (an inflammatory biomarker) using a smartphone application, nurse‐led annual telephone monitoring, a secure web‐based program for medication monitoring, videoconference clinics, a decision support tool to customize self‐management, a web‐based application for monitoring disease activity, and telemedicine virtual visits.…”

Section: Resultsmentioning

confidence: 99%

“…Disease characteristics of the participants varied among the studies. Of the 18 studies, eight (Abutaleb et al, 2018; Cross et al, 2019; de Jong et al, 2017; Del Hoyo et al, 2018; Krier et al, 2011; Li et al, 2017; Ruf et al, 2019; Sebastian et al, 2019) included adults with IBD of both subtypes (CD & UC), and participants with active disease and remission (inactive disease). Six of the studies (Cross et al, 2012; Elkjaer et al, 2010; Jackson et al, 2019; Pederson et al, 2014; Sebastian et al, 2019; Walsh et al, 2019) included participants with UC only; three of these studies included participants with mild to moderate UC (Elkjaer et al, 2010; Jackson et al, 2019; Pederson et al, 2014), and one study included subjects with CD (Pederson et al, 2012) who were in remission and or active disease.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review

Davis

Ross

Adatorwovor

et al. 2020

Research in Nursing & Health

View full text Add to dashboard Cite

Inflammatory bowel disease (IBD) is a chronic illness that is comprised of two major disorders: Crohn's disease and ulcerative colitis. Adults with IBD have adopted telehealth and mobile health (mHealth) interventions to improve their selfmanagement skills and symptom-monitoring. This systematic review aimed to evaluate the efficacy of telehealth and mHealth interventions and explore the benefits and challenges of these interventions in patients with IBD. This review used a convergent segregated approach to synthesize and integrate research findings, a methodology recommended by the Joanna Briggs Institute for mixed-methods systematic reviews. Databases searched included PubMed, CINAHL, Embase, Cochrane Controlled Trials Registry, and ClinicalTrials.gov. The search followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, which yielded sixteen quantitative and two qualitative articles. A narrative synthesis was performed to present the findings of quantitative and qualitative studies. Evidence from quantitative and qualitative studies was then integrated for a combined presentation. The results of quantitative analysis supported the efficacy of telehealth and mHealth interventions to improve patients' quality of life, medication adherence, disease activity, medication monitoring, disease-related knowledge and cost savings. While some participants in qualitative studies reported certain challenges of telehealth and mHealth interventions, most of the participants conferred the benefits of the interventions, including improved disease-related knowledge, communication between patients and providers, sense of reassurance, and appointment options. The evidence from quantitative and qualitative synthesis partially supported each other. 1 | INTRODUCTION Inflammatory bowel disease (IBD) is a chronic illness of the gastrointestinal (GI) tract that mainly encompasses two major disorders: Crohn's disease (CD) and ulcerative colitis (UC; Lee, Kwon, & Cho, 2018). Active inflammation of the GI tract is the key factor behind IBD (Stein & Shaker, 2015). The clinical presentation of IBD includes abdominal pain, diarrhea, bowel urgency, rectal bleeding, weight loss, nutritional deficiencies, and many other extraintestinal manifestations (Stein & Shaker, 2015). Additionally, other symptoms, such as anxiety, depression, sleep disturbances, and fatigue, are highly prevalent in adults with IBD (Conley et al., 2017). This symptom burden, coupled with the remitting-relapsing nature of the disease and many other factors, including low social and family support, female gender,

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review

Davis

Ross

Adatorwovor

et al. 2020

Research in Nursing & Health

View full text Add to dashboard Cite

show abstract

“…In a study of 219 participants, patients were randomized to receive either TELE-IBD messages at different frequencies or standard of care. Results measured by CCKNOW showed significant improvement in patients receiving messages every other week as compared to controls ( P =.03) and greater changes in scores in participants with lower baselines ( P <.01); however, after adjusting for race, site, and baseline, researchers found no significant changes between control and TELE-IBD groups [48-50].…”

Section: Resultsmentioning

confidence: 99%

Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review

Yin¹,

Hachuel²,

Pollak³

et al. 2019

J Med Internet Res

View full text Add to dashboard Cite

Background Digital health is poised to transform health care and redefine personalized health. As Internet and mobile phone usage increases, as technology develops new ways to collect data, and as clinical guidelines change, all areas of medicine face new challenges and opportunities. Inflammatory bowel disease (IBD) is one of many chronic diseases that may benefit from these advances in digital health. This review intends to lay a foundation for clinicians and technologists to understand future directions and opportunities together. Objective This review covers mobile health apps that have been used in IBD, how they have fit into a clinical care framework, and the challenges that clinicians and technologists face in approaching future opportunities. Methods We searched PubMed, Scopus, and ClinicalTrials.gov to identify mobile apps that have been studied and were published in the literature from January 1, 2010, to April 19, 2019. The search terms were (“mobile health” OR “eHealth” OR “digital health” OR “smart phone” OR “mobile app” OR “mobile applications” OR “mHealth” OR “smartphones”) AND (“IBD” OR “Inflammatory bowel disease” OR “Crohn's Disease” (CD) OR “Ulcerative Colitis” (UC) OR “UC” OR “CD”), followed by further analysis of citations from the results. We searched the Apple iTunes app store to identify a limited selection of commercial apps to include for discussion. Results A total of 68 articles met the inclusion criteria. A total of 11 digital health apps were identified in the literature and 4 commercial apps were selected to be described in this review. While most apps have some educational component, the majority of apps focus on eliciting patient-reported outcomes related to disease activity, and a few are for treatment management. Significant benefits have been seen in trials relating to education, quality of life, quality of care, treatment adherence, and medication management. No studies have reported a negative impact on any of the above. There are mixed results in terms of effects on office visits and follow-up. Conclusions While studies have shown that digital health can fit into, complement, and improve the standard clinical care of patients with IBD, there is a need for further validation and improvement, from both a clinical and patient perspective. Exploring new research methods, like microrandomized trials, may allow for more implementation of technology and rapid advancement of knowledge. New technologies that can objectively and seamlessly capture remote data, as well as complement the clinical shift from symptom-based to inflammation-based care, will help the clinical and health technology communities to understand the full potential of digital health in the care of IBD and other chronic illnesses.

show abstract

“…An increasing number of gastroenterologists have started utilising telemedicine for most clinic visits 59 . Telemedicine has been well studied in the inflammatory bowel disease (IBD) population, which has shown cost‐effectiveness, a decrease in hospitalisations, improving disease activity and improving disease‐related knowledge 60‐63 . It is essential to learn from shared experience in this situation and understand how telemedicine can become an integral part of the healthcare delivery even after the pandemic ends.…”

Section: Methods Of Literature Searchmentioning

confidence: 99%

Current and future implications of COVID‐19 on gastroenterology training and clinical practice

et al. 2020

View full text Add to dashboard Cite

show abstract

Inflammatory Bowel Disease Telemedicine Clinical Trial: Impact of Educational Text Messages on Disease-Specific Knowledge Over 1 Year

Cited by 18 publications

References 31 publications

Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review

Telehealth and mobile health interventions in adults with inflammatory bowel disease: A mixed‐methods systematic review

Digital Health Apps in the Clinical Care of Inflammatory Bowel Disease: Scoping Review

Current and future implications of COVID‐19 on gastroenterology training and clinical practice

Contact Info

Product

Resources

About